Elsevier

Physiology & Behavior

Volume 90, Issue 4, 16 March 2007, Pages 576-582
Physiology & Behavior

Tryptophan increases nocturnal rest and affects melatonin and serotonin serum levels in old ringdove

https://doi.org/10.1016/j.physbeh.2006.11.007Get rights and content

Abstract

The sleep promoting functions of melatonin have gained wide scientific attention due to the ability of this indole to provide relief from sleep inefficiency and the temporal relationship between its nocturnal rise in the blood and the “opening of the sleep gate” at night. However, little is known about the effects exerted by its precursor, the amino acid tryptophan. We studied the effect of a 7-day administration of two concentrations of tryptophan (125 and 300 kg b.w.) on the activity/rest rhythms of ringdove, aged 2–3 (young) and 10–12 (old) years, and on the serum levels of serotonin and melatonin. Activity pulses were logged before, during, and up to 5 days after the treatments. The animals received 125 or 300 mg/kg b.w. per animal/day at 09:00 h or at 19:00 h. Subsequently we chose the treatment which gave the best results in terms of nocturnal rest without affecting diurnal activity, i.e., 300 mg/kg b.w. administered to old animals at 09:00 h, 1 h after lights on, for the serotonin and melatonin measurements. During this treatment, the nocturnal and diurnal levels and amplitudes of serotonin and melatonin were all significantly higher than the corresponding levels before and after the treatment. In sum, our results point to an improvement of nocturnal rest in this animal model of old ringdove when administering 300 mg/kg tryptophan 1 h after lights on.

Introduction

Evidence from naturalistic observations supports the suggestion that the endogenous role of melatonin may be to enhance behaviour normally associated with night in both diurnal and nocturnal species, i.e., melatonin can be viewed as a neuroendocrine transducer promoting an increased propensity for “dark appropriate” behaviour [1]. The endogenous melatonin rhythm exhibits a close association with the endogenous circadian component of the sleep propensity rhythm. This has led to the idea that melatonin is an internal sleep “facilitator” in diurnally-active animals, and therefore useful in the treatment of insomnia and the readjustment of circadian rhythms [2]. Successful use of melatonin's chronobiotic properties has been reported in other sleep disorders associated with abnormal timing of the circadian system: jetlag, shiftwork, delayed sleep phase syndrome, and some sleep problems of the elderly [3]. The related indolamine, 5-HT, is known to increase the proportion of slow wave sleep [4], as well as being a waking neurotransmitter [5]. Also, the close relationship between serotonergic activity and the adjustments of circadian phase suggest that 5-HT also plays a role in the endogenous regulation of the circadian clock [6].

Despite the major role that melatonin and 5-HT play in sleep, little is known about the effect of tryptophan, the common precursor in their biosynthesis. Tryptophan administered in the diet is known to increase the availability of 5-HT in the brain, the EEG delta potential, and the amount of NREM [7]. It has also been observed in mammals that orally ingested tryptophan increases the brain levels of 5-HT during the day and the circulating levels of melatonin during the immediately following night [8], and recently it has been shown in our animal model that this amino acid significantly increases the hippocampus, striatum, and hypothalamus 5-HT contents [9], and reduces the expression of c-fos in the suprachiasmatic nucleus [10] whose levels are high in several cerebral regions during spontaneous waking or sleep deprivation and fall after a few hours of sleep [11].

The aim of the present work was to investigate the effect on rest/activity of oral administration of tryptophan to both young and old diurnal monophasic animals (ringdove, Streptopelia risoria). Once the concentration of tryptophan that was most effective in improving nocturnal rest without affecting diurnal activity had been established, the effects of these treatments on the serum 5-HT and melatonin levels were studied.

Section snippets

Animals

Male and female ringdove (S. risoria) of 2–3 years of age (young) and 10–12 years of age (old; average life span of 15 years) weighing 150 ± 20 g were used in the study (n = 10, per age group). The animals were bred in our department and individually housed in 40 × 40 × 45 cm cages under controlled environmental conditions (22 °C; 70% humidity), kept under a 12/12 h light/dark photoperiod (darkness from 20:00 to 08:00), and fed ad libitum (food and water). For the activimetry studies, the animals were

Experiment A: treatment of the animals and measurements of the activity/rest rhythms

Fig. 1 shows the total day and night activity pulses obtained during and after treatment of the young and old birds with tryptophan (125 and 300 mg/kg b.w.) at 09:00 h (Fig. 1A and B) or at 19:00 h (Fig. 1C and D), at the beginning (day 1), midway through (day 3), and at the end (day 7) of each treatment period, as well as on days 2 and 5 following the termination of that treatment. The results are expressed as percentages of the basal value obtained as the mean of measurements made on the

Discussion

The essential amino acid l-tryptophan is the precursor of the monoamine neurotransmitter 5-HT and the pineal indole melatonin. In man and other diurnal animals, melatonin's high nocturnal levels serve the organism as a regulatory signal for sleep promotion [15], [16], while 5-HT is responsible during wakefulness for initiating a cascade of post-synaptic genomic processes [4] leading to a homeostatic regulation of slow wave sleep [4] and acting as a positive modulator of melatonin synthesis [17]

Acknowledgements

This research was supported by grants from the Spanish Ministry of Science and Technology (BFI2002-04583-FC02-01) and Consejería de Infraestructuras y Desarrollo Tecnológico (Junta de Extremadura, 3PR05A053). S.D. Paredes was the beneficiary of a grant from the Consejería de Infraestructuras y Desarrollo Tecnológico — Fondo Social Europeo (Junta de Extremadura, FIC02A049). The authors would like to express their thanks to Elena Circujano Vadillo, Ricardo Megías Cebrino, and Ana Royano Sánchez

References (50)

  • M.H. Pietraszek et al.

    Circadian rhythm of serotonin: influence of age

    Thromb Res

    (1990)
  • I.V. Zhdanova

    Melatonin as a hypnotic: pro

    Sleep Med Rev

    (2005)
  • M.P. Terron et al.

    Melatonin and aging: in vitro effect of young and mature ring dove physiological concentrations of melatonin on the phagocytic function of heterophils from old ring dove

    Exp Gerontol

    (2002)
  • E.M. Tarlow et al.

    Diel changes in plasma melatonin and corticosterone concentrations in tropical Nazca boobies (Sula granti) in relation to moon phase and age

    Gen Comp Endocrinol

    (2003)
  • M.C. Boadle-Biber

    Regulation of serotonin synthesis

    Prog Biophys Mol Biol

    (1993)
  • M. Hasegawa et al.

    Application of in vivo microdialysis to pineal research in birds: measurement of circadian rhythms of melatonin

    Neurosci Biobehav Rev

    (1994)
  • K. Yaga et al.

    Tryptophan loading increases daytime serum melatonin levels in intact and pinealectomized rats

    Life Sci

    (1993)
  • N. Murakami et al.

    Effect of melatonin on circadian rhythm, locomotor activity and body temperature in the intact house sparrow, Japanese quail and owl

    Brain Res

    (2001)
  • R.J. Reiter

    Melatonin: clinical relevance

    Best Pract Res Clin Endocrinol Metab

    (2003)
  • J. Gao et al.

    Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdala on sleep–waking cycle of rats

    Brain Res

    (2002)
  • S.R. Pandi-Perumal et al.

    Melatonin and sleep in aging population

    Exp Gerontol

    (2005)
  • M. Münch et al.

    Age-related attenuation of the evening circadian arousal signal in humans

    Neurobiol Aging

    (2005)
  • D.J. Skene et al.

    Melatonin rhythmicity: effect of age and Alzheimer's disease

    Exp Gerontol

    (2003)
  • C. Cajochen et al.

    Role of melatonin in the regulation of human circadian rhythms and sleep

    J Neuroendocrinol

    (2003)
  • M. Jouvet

    Sleep and serotonin: an unfinished story

    Neuropsychopharmacology

    (1999)
  • Cited by (29)

    • Jerte Valley cherry-based product modulates serum inflammatory markers in rats and ringdoves

      2012, Journal of Applied Biomedicine
      Citation Excerpt :

      The amino acid tryptophan, the neurotransmitter serotonin, and the indole melatonin are present in various fruits and vegetables (Paredes et al. 2009a). These bioactive compounds participate in the physiological regulation of sleep as well as in the improvement of antioxidant defences (Paredes et al. 2007a, b, c). Moreover, melatonin possesses both immunomodulatory (Carrillo-Vico et al. 2005a) and anti-inflammatory (Carrillo-Vico et al. 2005b) properties, and is also a potent free radical scavenger (Tan et al. 1993).

    • A cherry nutraceutical modulates melatonin, serotonin, corticosterone, and total antioxidant capacity levels: Effect on ageing and chronotype

      2011, Journal of Applied Biomedicine
      Citation Excerpt :

      However, cherries contain other important antioxidants, e.g., anthocyanins and polyphenols that are also absorbed from the gut and influence the total antioxidant capacity of serum (Garrido et al. 2009, 2010a). That tryptophan, serotonin, and melatonin may be involved in the observed increase in the circulating levels of serotonin, melatonin and serum TAC observed in both rats and ringdoves, is reinforced by previous reports showing that dietary-rich tryptophan supplementation increases the brain and blood levels of serotonin, as well as modulating the circulating levels of melatonin (Garau et al. 2006, Paredes et al. 2007e). The increase of serum serotonin observed after the 10-day consumption of the cherry-based nutraceutical product would indicate a higher availability of tryptophan which, after passing through the blood-brain barrier, would be converted into serotonin, thus increasing the production of this neurotransmitter in the brain as has been observed in the ringdove (Garau et al. 2006) and other animal species (Fernstrom and Wurtman 1971, Huether et al. 1993, Esteban et al. 2004).

    View all citing articles on Scopus
    View full text